LISI GROUP has entered into exclusive negotiations with SK CAPITAL to acquire its LISI MEDICAL division

SK CAPITAL, a US transformational private investment firm, submitted a firm offer to LISI GROUP today in order to acquire all subsidiaries forming together the LISI MEDICAL division (meaning LISI MEDICAL - Head office in Neyron, LISI MEDICAL ORTHOPAEDICS - Caen, LISI MEDICAL FASTENERS - Neyron and LISI MEDICAL REMMELE - Minneapolis US).

Additionally, LISI Group is considering becoming a partner in SK CAPITAL’s development strategy by taking an approximately 10% stake in the holding company that will hold these activities acquired by SK CAPITAL, thus joining the proposed transformation project.

This acquisition project will allow LISI MEDCIAL to benefit from the full support of SK CAPITAL in the deployment of its strategy both in terms of organic growth and acquisitions.

The transaction remains subject to consultation with the employee representative bodies of the relevant French entities as well as obtaining the required authorizations. Subject to receiving these necessary authorizations and opinions, the transaction could become effective during the second half of 2025.

LISI Group will comment on this transaction project, on next July 25th when announcing its first-half results for the period ended June 30, 2025.